Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Conestoga underperformed in 2025 due to a narrow, speculative 'low quality' rally in unprofitable stocks, but holds a highly bullish outlook for Small Caps in 2026 based on extreme valuation discounts and accelerating earnings growth.
Full Quick Take
Conestoga underperformed in 2025 due to a narrow, speculative 'low quality' rally in unprofitable stocks, but holds a highly bullish outlook for Small Caps in 2026 based on extreme valuation discounts and accelerating earnings growth.
The fund posted moderate positive returns in Q4 2025, slightly underperforming its benchmark. Managers are tilting toward equities over credit, prioritizing dividend-oriented and defensive sectors, and maintaining an underweight to duration amid ongoing rate volatility.
Full Quick Take
The fund posted moderate positive returns in Q4 2025, slightly underperforming its benchmark. Managers are tilting toward equities over credit, prioritizing dividend-oriented and defensive sectors, and maintaining an underweight to duration amid ongoing rate volatility.
The Fund outperformed its benchmark in 2Q25 with a 1.62% return, driven by successful high-yield corporate bond allocations and selective investment-grade security choices.
Full Quick Take
The Fund outperformed its benchmark in 2Q25 with a 1.62% return, driven by successful high-yield corporate bond allocations and selective investment-grade security choices.
The fund underperformed its value benchmark during Q2 2025 due to lagging healthcare and industrial selections, but continues to reposition defensively in high-quality consumer staples and utilities with attractive valuations.
Full Quick Take
The fund underperformed its value benchmark during Q2 2025 due to lagging healthcare and industrial selections, but continues to reposition defensively in high-quality consumer staples and utilities with attractive valuations.
The manager is taking advantage of higher yields in longer-duration High Quality bonds while reducing exposure to expensive, narrow-spread credit instruments.
Full Quick Take
The manager is taking advantage of higher yields in longer-duration High Quality bonds while reducing exposure to expensive, narrow-spread credit instruments.
Silver Ring Value Partners maintains a highly disciplined, patient value investing approach, opting to hold 29% cash rather than compromise on strict quality standards.
Full Quick Take
Silver Ring Value Partners maintains a highly disciplined, patient value investing approach, opting to hold 29% cash rather than compromise on strict quality standards.